GL1X · GenesisL1 explorer

MolNFT v2 · #51027 · protein

Crystal Structure Of Human Ste20-Like Kinase Bound To 4-(4-(5- Cyclopropyl-1H-pyrazol-3-ylamino)-quinazolin-2-ylamino)-phenyl)- acetonitrile

2UV2 · STE20-like serine-threonine kinase: “Crystal Structure Of Human Ste20-Like Kinase Bound To 4-(4-(5…”. X-ray diffraction at 2.3, 2 ligands (GVD, SCN), 3 pockets (best druggability 0.57). MolNFT v2 #51027 on GenesisL1: 3D structure…

PDB
2UV2
Type
protein
Length
286 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.3
Source
HOMO SAPIENS
Molecule
STE20-like serine-threonine kinase
EC
2.7.11.1
UniProt
Q9H2G2
Ligands
GVD, SCN
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · resolution 2.3 · 1 distinct chain · 40% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASTE20-like serine-threonine kinase (EC 2.7.11.1)protein28640% helix, 19% strandQ9H2G2

Ligands and binding sites

  • GVD · [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile · ligand · chains A
  • SCN · Thiocyanate ion · ion · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · 5 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12130.570.7923SCN, GVD
21000.380.7519empty
3550.340.7814EDO

Compared structures

  • 2UV2 · Crystal structure of human STE20-like kinase bound to 4-(4-(5… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H2G2 · AlphaFold monomer V2.0 prediction for STE20-like SERINE/THREONINE- protein kinase (Q9H2G2) · a predicted model of the same protein · chain A against A, TM-score 0.89

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.